Feldman DN - Search Results

1

Characteristics of Hospitalizations for Heart Failure with Preserved Ejection Fraction.

Goyal P, Almarzooq ZI, Horn EM, Karas MG, Sobol I, Swaminathan RV, Feldman DN, Minutello RM, Singh HS, Bergman GW, Wong SC, Kim LK. Goyal P, et al. Among authors: feldman dn. Am J Med. 2016 Jun;129(6):635.e15-26. doi: 10.1016/j.amjmed.2016.02.007. Am J Med. 2016. PMID: 27215991

2

Angiographic pattern of restenosis following implantation of overlapping sirolimus-eluting (Cypher) stents.

Minutello RM, Bhagan S, Feldman D, Sharma A, Hong MK, Wong SC. Minutello RM, et al. Am J Cardiol. 2006 Feb 15;97(4):499-501. doi: 10.1016/j.amjcard.2005.09.082. Epub 2006 Jan 4. Am J Cardiol. 2006. PMID: 16461045

3

Comparison of outcomes of percutaneous coronary interventions in patients of three age groups (<60, 60 to 80, and >80 years) (from the New York State Angioplasty Registry).

Feldman DN, Gade CL, Slotwiner AJ, Parikh M, Bergman G, Wong SC, Minutello RM; New York State Angioplasty Registry. Feldman DN, et al. Am J Cardiol. 2006 Nov 15;98(10):1334-9. doi: 10.1016/j.amjcard.2006.06.026. Epub 2006 Sep 28. Am J Cardiol. 2006. PMID: 17134624

4

Outcomes following immediate (ad hoc) versus staged percutaneous coronary interventions (report from the 2000 to 2001 New York State Angioplasty Registry).

Feldman DN, Minutello RM, Gade CL, Wong SC. Feldman DN, et al. Am J Cardiol. 2007 Feb 15;99(4):446-9. doi: 10.1016/j.amjcard.2006.09.093. Epub 2006 Dec 21. Am J Cardiol. 2007. PMID: 17293181

5

Impact of bivalirudin on outcomes after percutaneous coronary revascularization with drug-eluting stents.

Feldman DN, Wong SC, Gade CL, Gidseg DS, Bergman G, Minutello RM. Feldman DN, et al. Am Heart J. 2007 Oct;154(4):695-701. doi: 10.1016/j.ahj.2007.06.023. Epub 2007 Aug 20. Am Heart J. 2007. PMID: 17892994

6

Long-term clinical benefit of sirolimus-eluting stents compared to bare metal stents in the treatment of saphenous vein graft disease.

Minutello RM, Bhagan S, Sharma A, Slotwiner AJ, Feldman DN, Cuomo LJ, Wong SC. Minutello RM, et al. Among authors: feldman dn. J Interv Cardiol. 2007 Dec;20(6):458-65. doi: 10.1111/j.1540-8183.2007.00301.x. J Interv Cardiol. 2007. PMID: 18042050 Free article.

7

Frequency and outcomes of provisional glycoprotein IIb/IIIa blockade in patients receiving bivalirudin during percutaneous coronary intervention.

Feldman DN, Wong SC, Bergman G, Minutello RM. Feldman DN, et al. J Invasive Cardiol. 2009 Jun;21(6):258-63. J Invasive Cardiol. 2009. PMID: 19494400

8

Relation of troponin I levels following nonemergent percutaneous coronary intervention to short- and long-term outcomes.

Feldman DN, Minutello RM, Bergman G, Moussa I, Wong SC. Feldman DN, et al. Am J Cardiol. 2009 Nov 1;104(9):1210-5. doi: 10.1016/j.amjcard.2009.06.032. Am J Cardiol. 2009. PMID: 19840564

9

Efficacy of high-dose clopidogrel treatment (600 mg) less than two hours before percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes.

Feldman DN, Fakorede F, Minutello RM, Bergman G, Moussa I, Wong SC. Feldman DN, et al. Am J Cardiol. 2010 Feb 1;105(3):323-32. doi: 10.1016/j.amjcard.2009.09.034. Epub 2009 Dec 22. Am J Cardiol. 2010. PMID: 20102943

10

Efficacy and safety of bivalirudin in patients with diabetes mellitus undergoing percutaneous coronary intervention in current clinical practice.

Kim LK, Wong SC, Minutello RM, Bergman G, Feldman DN. Kim LK, et al. Among authors: feldman dn. J Invasive Cardiol. 2010 Mar;22(3):94-100. J Invasive Cardiol. 2010. PMID: 20197573

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

184 results

Search Page

Filters